Esperion Therapeutics | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
AbbVie USD 5.52B 1.73B 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 119.52M 1.51M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Cipla INR 8B 1.22B 2025-03
CSL 1.52B 133M 2024-12
Cytokinetics USD 938.22M 843.36M 2025-03
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Geron USD 85.61M 6.59M 2025-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
United Therapeutics USD 1.9B 202.7M 2025-03



Esperion Therapeutics Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.